Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
26 Mar 2026
EBMT 2026: Autoantibodies Track Long-Term Immune Recovery
Autoantibody expression after paediatric stem cell transplantation reflects immune reconstitution rather than chronic graft versus host disease risk, highlighting alternative biomarkers.
26 Mar 2026
EBMT 2026: Machine Learning Predicts Graft Failure After Transplant
A machine learning approach reveals structural HLA biomarkers linked to graft failure, offering a new strategy for donor selection in transplantation.
25 Mar 2026
EBMT 2026: Memory T Cell Therapy Boosts Post-transplant Immunity
CD45RA depleted memory T cell therapy shows encouraging results in treating infections after transplant, with high survival and viral clearance rates in early findings.
25 Mar 2026
EBMT 2026: Gene Therapy Adoption Gaps in Sickle Cell Care
Survey data reveal strong support for gene therapy in sickle cell disease, but inconsistent referral practices, limited knowledge, and insurance barriers hinder implementation.
15 Mar 2026
Ribosome Biogenesis Target Identified in Acute Myeloid Leukaemia
A study identifies the ribosome biogenesis factor MYBBP1A as essential for acute myeloid leukaemia cell growth, revealing a potential therapeutic vulnerability.
15 Mar 2026
Epigenetic Silencing Challenges AAV Gene Therapy Durability
Analysis of patient liver biopsies and cell models suggests epigenetic silencing may limit durability of AAV gene therapy, offering insight into long term variability in haemophilia treatment.
14 Mar 2026
Multiple Myeloma Immunotherapy Response Tied to T Cell Fitness
A transcriptional classifier identifies tumour reactive T cells in multiple myeloma and predicts response to immunotherapy, offering a potential biomarker for treatment selection.
14 Mar 2026
MEF2C Stability Mechanism Identified in Aggressive AML
A new study identifies a paralog dependency regulating MEF2C stability in acute myeloid leukaemia and demonstrates a peptide approach that suppresses disease progression in preclinical models.
28 Feb 2026
Swallowable Gastric Balloon Approved for Weight Loss
At 48 weeks, 58% of participants in the treatment group lost more than 5% of their total body weight, meeting the responder rate co-primary endpoint.
28 Feb 2026
Antibody Therapy Improves Chronic Spontaneous Urticaria Symptoms
Complete response, defined as UAS7=0 at Week 12, was achieved in 22.9% of patients receiving 75 mg, 51.1% receiving 150 mg, and 37.5% receiving 300 mg.
←
1
2
3
…
20
21
22
23
24
25
26
…
105
106
107
→
We’ve noticed you’re accessing
from
North/South America.
View
View